Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Classement en actions #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Prix de l'action
$8.92
Dernière synchronisation: 2024-10-18
Capitalisation boursière
$674.03M
Changement (1 jour)
-5.14%
Changement (1 an)
0.00%
Pays
KR
Échange Jeisys Medical Inc. (287410)

Catégorie

Bénéfices pour Jeisys Medical Inc. (287410)
Bénéfices en Jun 2024 TTM : $27.72M
Selon les derniers rapports financiers de Jeisys Medical Inc., les bénéfices actuels de l'entreprise sont de $27.72M. En 2022, l'entreprise a réalisé un bénéfice de $26.85M, une augmentation par rapport à celui de 2021 qui était de $11.01M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Jeisys Medical Inc. de 2020 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $27.72M 1.10%
2023 $27.42M 2.12%
2022 $26.85M 143.83%
2021 $11.01M 45.55%
2020 $7.57M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$7.51B 26,993.21%
US
$5.15B 18,469.54%
US
$5.56B 19,966.50%
IE
$3.86B 13,827.16%
US
- -
DE